Ars Pharmaceuticals Inc (SPRY)
Net Income Growth
-348.66%
TTM · Period ending:
SPRY Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-348.66%period ending
Latest reported-348.66%period ending
SPRY TTM Net Income YoY % (36.34% → -348.66%)
Year-over-year change
High-resolution chart · PNG
SPRY net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| -348.6578% | |
| -1,165.0224% | |
| -2,241.7604% | |
| -63.001% | |
| -7.0804% | |
| 68.5085% | |
| 114.7117% | |
| 20.3193% | |
| 15.9365% | |
| -17.2269% | |
| -56.7528% | |
| -142.6889% | |
| -116.6653% | |
| -85.5558% | |
| -71.3284% | |
| 9.9156% | |
| 14.6473% | |
| 22.4951% | |
| 36.3448% |